Molecular Changes in Chronic Myeloid Leukemia During Tyrosine Kinase Inhibitors Treatment. Focus on Immunological Pathways.
Janowski M, Ulańczyk Z, Łuczkowska K, Sobuś A, Rogińska D, Pius-Sadowska E, Gniot M, Kozłowski K, Lewandowski K, Helbig G, Machaliński B, Paczkowska E.
Janowski M, et al. Among authors: roginska d.
Onco Targets Ther. 2022 Oct 10;15:1123-1141. doi: 10.2147/OTT.S371847. eCollection 2022.
Onco Targets Ther. 2022.
PMID: 36238136
Free PMC article.